Skip to main content

Main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers

Secondary navigation

  • Value added services
  • CSR
  • About us

SearchSearch results for: “”

34 results

Séminaire Compliance & Sustainability

Le lundi 12 juin, Stibbe organise le séminaire Compliance & Sustainability. N'hésitez pas à vous inscrire.

Seminarie Compliance & Sustainability

Op maandag 12 juni organiseert Stibbe het seminarie Compliance & Sustainability. Aarzel niet om u in te schrijven.

Het federale regeerakkoord door een publiekrechtelijke bril

De nieuwe federale regering, die zichzelf een echte “hervormingsregering” noemt, heeft ambitieuze plannen voor het publiekrecht. In deze blogpost ontdek je enkele belangrijke hervormingen die de komende vijf jaar op de agenda staan.

Stibbe advises LDA Capital

Stibbe assisted LDA Capital, a US-based global investment group, with its capital commitment agreement with Mithra, a company dedicated to Women's Health.

Stibbe advises DW Healthcare Partners

Stibbe advised DW Healthcare Partners, a private equity investment firm, on the acquisition of CEFALY Technology, a company active in the healthcare sector.

Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe

Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe.

Stibbe advises pharmaceutical multinational

Stibbe assisted a pharmaceutical multinational in complex litigations.

Stibbe advises several banks in the aftermath of the Lernaut & Hauspie debacle

Stibbe represented Artesia Bank Nederland in the Lernout & Hauspie case before the Court of Appeal in Ghent regarding the possible confiscation of shares worth EUR 30 million. We also assisted Dexia Bank in the L&H case before Belgium's Supreme Court.

Stibbe represents Belgian Ministry of Finance

Stibbe represented the Ministry of Finance in annulment proceedings pursued by the Flemish Bar Council before the Constitutional Court against the Belgian Preventative Money Laundering Act.

Stibbe advises KBC Securities

Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels.

Stibbe represents aviation client

Stibbe represented an aviation client before a Belgian criminal court in a liability case relating to the fire in a hangar at the Belgian National Airport. 

Stibbe advises clients on delisting from Iran Sanction list

Stibbe assisted a number of clients in obtaining a delisting from the Iran Sanction list and in obtaining clearance for financial flows from Iran to our clients' subsidiaries.

Stibbe represents Flemish Media Regulator

Stibbe represented the Flemish Media Regulator before the Court of Appeal following a claim by various Belgian cable operators.

Stibbe advises worldwide seeds leader

Stibbe assisted a worldwide seeds leader in negotiations on cooperation deals with competitors.

Stibbe advises Isabel

Stibbe advised Isabel, an international banking automation and electronic invoicing services provider, on its business model of trust services and compliance with various regulatory bodies.

Belgian data protection authority fines hospital after data breach for taking insufficient data protection measures

In 2021, a Belgian hospital fell victim to a ransomware attack that disrupted critical operations and compromised the personal data of 300,000 people. As a result, the Belgian data protection authority imposed a fine of €200,000 three years later.

Stibbe advises leading pharmaceutical company

Stibbe assisted a leading pharmaceutical company in identifying the most cost-effective way to obtain in Belgium an improved pricing and reimbursement for new fixed-dose combination products composed of off-patent ingredients.

Stibbe advises client in the pharmaceutical sector

Stibbe assisted a client in the pharmaceutical sector with conducting an in-depth legal assessment regarding the scope and modalities of the safety features to be added to (the packaging of) medicinal products.

Pagination

  • Current page 1
  • Page 2
  • Next page
Reset filters
Date
Content type
  • Article (10)
  • Event (3)
  • Matter (21)
Expertise
  • (-) Compliance, Sanctions and Risk (19)
  • (-) Healthcare and Life Sciences (18)
  • Audit Firms and Accountancy (3)
  • Banking and Finance (60)
  • Capital Markets (41)
  • Corporate and M&A (132)
  • Corporate Investigations (5)
  • Criminal Law and Enforcement (27)
  • Employment, Benefits and Pensions (36)
  • Energy, Industry and Climate (58)
  • Environment and Planning (86)
  • ESG & Sustainability (22)
  • EU and Competition Law (52)
  • Financial Regulation (23)
  • Infrastructure and Mobility (48)
  • Insurance (10)
  • Intellectual Property (33)
  • Investment Funds (28)
  • Litigation and Arbitration (48)
  • Mass Litigation (1)
  • Privacy and Data Protection (46)
  • Private Equity (32)
  • Procurement Law (34)
  • Public Law (103)
  • Real Estate (113)
  • Restructuring and Insolvency (11)
  • Sports (5)
  • Tax (61)
  • Tech (31)
  • Technology, Media and Telecommunications (86)
  • Unfair Competition and Consumer Protection (96)
Jurisdiction
  • (-) BE Law (34)
  • EU Law (29)
  • LU Law (10)
  • NL Law (151)
Language
  • Dutch (2)
  • English (30)
  • French (2)

Footer main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers
© 2026 Stibbe

Footer navigation

  • Contact
  • Disclaimer
  • General Conditions
  • Register of legal practice areas
  • Privacy and Cookie Policy
  • Important Information